Patrick K. Owiafe
Impact in
- Infectious Diseases top 2%
- Tuberculosis Research and Epidemiology
- Epidemiology top 5%
- Mycobacterium research and diagnosis
- Pneumocystis jirovecii pneumonia detection and treatment
- Pneumonia and Respiratory Infections
Papers in
-
- Tuberculosis Research and Epidemiology 17
- Epidemiology 14
- Mycobacterium research and diagnosis 9
- Pneumocystis jirovecii pneumonia detection and treatment 4
- Pneumonia and Respiratory Infections 3
- Co-authors
- Roger H. Brookes (10 shared papers)Philip C. Hill (10 shared papers)Richard A. Adegbola (7 shared papers)Simon Donkor (10 shared papers)David Jeffries (6 shared papers)Helen A. Fletcher (4 shared papers)Abdulrahman S. Hammond (6 shared papers)Martin O. C. Ota (11 shared papers)
- Journals
- Vaccine (3 papers)Clinical Infectious Diseases (2 papers)Tuberculosis (2 papers)PLoS ONE (2 papers)Human Vaccines & Immunotherapeutics (1 paper)
- Partner nations
- GambiaUnited KingdomGhana
In The Last Decade
Patrick K. Owiafe
25 papers receiving 788 citations
Peers
Comparison fields: 5 of 64
- Infectious Diseases 635
- Epidemiology 528
- Immunology 285
- Virology 32
- Microbiology 37
Countries citing papers authored by Patrick K. Owiafe
This map shows the geographic impact of Patrick K. Owiafe's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Patrick K. Owiafe with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Patrick K. Owiafe more than expected).
Fields of papers citing papers by Patrick K. Owiafe
This network shows the impact of papers produced by Patrick K. Owiafe. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Patrick K. Owiafe. The network helps show where Patrick K. Owiafe may publish in the future.
Co-authors
The 25 scholars most cited alongside Patrick K. Owiafe, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 25 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2006 | 162 | |
| 2 | 2004 | 137 | |
| 3 | 2004 | 60 | |
| 4 | 2004 | 59 | |
| 5 | 2012 | 44 | |
| 6 | 2014 | 42 | |
| 7 | 2006 | 42 | |
| 8 | 2011 | 41 | |
| 9 | 2008 | 40 | |
| 10 | 2015 | 33 | |
| 11 | 2019 | 20 | |
| 12 | 2012 | 15 | |
| 13 | 2016 | 15 | |
| 14 | 2007 | 12 | |
| 15 | 2013 | 12 | |
| 16 | 2017 | 11 | |
| 17 | 2007 | 10 | |
| 18 | 2014 | 10 | |
| 19 | 2014 | 9 | |
| 20 | 2017 | 9 |
About Patrick K. Owiafe
Patrick K. Owiafe is a scholar working on Infectious Diseases, Epidemiology, Surgery, Immunology and Molecular Biology, having authored 25 papers that have together received 810 indexed citations. Recurring topics across this work include Tuberculosis Research and Epidemiology (17 papers), Mycobacterium research and diagnosis (9 papers), Immunodeficiency and Autoimmune Disorders (6 papers), Immune responses and vaccinations (5 papers), Pneumocystis jirovecii pneumonia detection and treatment (4 papers), Pneumonia and Respiratory Infections (3 papers), Diagnosis and treatment of tuberculosis (3 papers) and vaccines and immunoinformatics approaches (3 papers). The work is most often cited by research in Infectious Diseases (635 citations), Epidemiology (528 citations), Immunology (285 citations), Virology (32 citations) and Microbiology (37 citations). Patrick K. Owiafe has collaborated with scholars based in Gambia, United Kingdom and Ghana. Frequent co-authors include Roger H. Brookes, Philip C. Hill, Richard A. Adegbola, Simon Donkor, David Jeffries, Helen A. Fletcher, Abdulrahman S. Hammond, Martin O. C. Ota, Moses D. Lugos and Dolly Jackson-Sillah. Their work appears in journals such as Vaccine, Clinical Infectious Diseases, Tuberculosis, PLoS ONE and Human Vaccines & Immunotherapeutics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.